Close

Analyst Ratings for Beam Therapeutics Inc (BEAM) [Buys]

BEAM Rating Summary

BEAM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BEAM
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $50.33 (+48.7%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/29/2024 JPMorgan
» Updated 2/27/2024
Eric Joseph Upgrade Overweight
(Neutral)
44.00
(40.00)
24.92
(33.85)
35.83% Details
12/20/2022 BMO Capital Kostas Biliouris Upgrade Outperform
(Market Perform)
66.00
(61.00)
42.54
(33.85)
-20.43% Details
Like BEAM Ratings? Also take a look at LLY

BEAM Ratings News